979 
Diastolic Dysfunction is Common in Asymptomatic HIV Patients
Priscilla Hsue*1, H Farah1, A Bolger1, S Palav2, S Ahmed2, A Schnell1, S Deeks1, J Martin1, and D Waters1
1Univ of California, San Francisco, US and 2San Francisco Gen Hosp, CA, US
Background: The
mechanism by which HIV infection increases cardiac events remains unclear. The
purpose of this study was to determine the prevalence of systolic and diastolic
dysfunction in a contemporary group of asymptomatic HIV patients.
Methods: We performed echocardiography in 196 HIV-infected adults and
52 uninfected controls. Left ventricular (LV) ejection fraction (EF), left
ventricular mass indexed to the body surface area, and diastolic function were
assessed according to the American Society of Echocardiography standards.
Results: The average age was 47±8 years and 85% were male. Of the HIV
patients, 26% had hypertension, 35% were cigarette smokers, and 38% used intravenous
drugs. The median duration of HIV infection was 15 years (IQR 11 to 18), 82%
were on ART, and 63% had an undetectable viral load. As shown in the table, LV
mass index was higher in HIV patients, EF was similar in both groups, and 9
(4.6%) of the HIV patients had evidence of LV systolic dysfunction (defined as
an EF <50%); 49% of HIV patients had diastolic dysfunction (vs 29%, p
= 0.008); 98 HIV patients had stage I diastolic dysfunction while 2 had stage
II diastolic dysfunction. After controlling for diabetes mellitus, intravenous
drug use, and prior coronary artery disease, HIV-infection was independently
associated with 2.48 higher odds of diastolic dysfunction (95%CI 1.17 to 5.25, p
= 0.017) along with age, hypertension, and EF. Duration of protease inhibitor
therapy, CD4 count, and HIV viral load were not associated with diastolic
dysfunction.
Conclusions: Asymptomatic HIV-infected patients had a higher prevalence
of cardiac abnormalities (higher LV mass and diastolic dysfunction) compared to
controls. HIV infection was independently associated with diastolic
dysfunction. Diastolic dysfunction in HIV patients was only partly related to
age, hypertension, and decreased EF. Future studies are needed to ascertain the
etiology and natural history of diastolic dysfunction in HIV-infected patients.
|
|
HIV patients
(n = 196)
|
Controls
(n = 52)
|
p value
|
|
LV mass index
|
78.5±17 g/m2
|
69.1±14 g/m2
|
<0.001
|
|
EF%
|
62
|
62
|
0.95
|
|
LV dysfunction (%)
|
4.6
|
0
|
0.14
|
|
LVH(%)
|
11
|
4
|
0.13
|
|
Diastolic dysfunction (%)
|
49
|
29
|
0.008
|
|